Abstract
Neutropenic patients are at particularly high risk of infection, with fever being the only sign they present with in the majority of cases. An etiological diagnosis is made in just 20% to 30% of febrile episodes. Early diagnosis and effective treatment are crucial for decreasing morbidity and mortality in this population. The treatment of fever in neutropenic patients includes intravenous beta-lactam antibiotics such as cefepime. Multidrug-resistant pathogens are emerging and there are few new anti-infectious agents being developed. Therefore, a rational use of antimicrobial agents is fundamental.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have